Download presentation
Presentation is loading. Please wait.
Published byGregers Lindegaard Modified over 5 years ago
1
Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient Jeff T Edwards, BS, CCP, James K Hamby, BS, CCP, Neil K Worrall, MD The Annals of Thoracic Surgery Volume 75, Issue 5, Pages (May 2003) DOI: /S (02) Copyright © 2003 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Timeline for Argatroban administration and resultant dose-response in the ACT and HiTT. Open bars = ACT; filled bars = HiTT. (ACT = activated clotting time; CPB = cardiopulmonary bypass; HiTT = high-dose thrombin time.) The Annals of Thoracic Surgery , DOI: ( /S (02) ) Copyright © 2003 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.